While administration of STZ in rodents reliably produces hyperglycemia due to destruction of insulin secreting β-cells in pancreatic islets, other features of DM are lacking, such as immunological aspects of type 1, or insulin-resistance of type 2 diabetes [34]. Here, INS is linked to diabetes mellitus.